These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 15743896
21. Topical microbicides: the time has come. Dhawan D, Keller M, Klotman ME. AIDS Read; 2006 Mar; 16(3):144-8, 155-8, 161; discussion 148, 156-7. PubMed ID: 16538955 [Abstract] [Full Text] [Related]
22. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety. Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC. J Infect Dis; 2007 May 01; 195(9):1332-9. PubMed ID: 17397004 [Abstract] [Full Text] [Related]
23. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Strick LB, Wald A, Celum C. Clin Infect Dis; 2006 Aug 01; 43(3):347-56. PubMed ID: 16804851 [Abstract] [Full Text] [Related]
24. Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides. Rusnati M, Vicenzi E, Donalisio M, Oreste P, Landolfo S, Lembo D. Pharmacol Ther; 2009 Sep 01; 123(3):310-22. PubMed ID: 19447134 [Abstract] [Full Text] [Related]
25. Introduction: Is viral shedding a surrogate marker for transmission of genital herpes? Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ. Antiviral Res; 2004 Aug 01; 63 Suppl 1():S3-9. PubMed ID: 15450380 [Abstract] [Full Text] [Related]
27. Topical application of polyethylenimine as a candidate for novel prophylactic therapeutics against genital herpes caused by herpes simplex virus. Hayashi K, Onoue H, Sasaki K, Lee JB, Kumar PK, Gopinath SC, Maitani Y, Kai T, Hayashi T. Arch Virol; 2014 Mar 01; 159(3):425-35. PubMed ID: 24046087 [Abstract] [Full Text] [Related]
28. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity. Neyts J, De Clercq E. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):8-12. PubMed ID: 7648289 [Abstract] [Full Text] [Related]
30. Genital herpes and human immunodeficiency virus: double trouble. Celum C, Levine R, Weaver M, Wald A. Bull World Health Organ; 2004 Jun 01; 82(6):447-53. PubMed ID: 15356938 [Abstract] [Full Text] [Related]
31. The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges. Harandi AM. J Clin Virol; 2004 Jul 01; 30(3):207-10. PubMed ID: 15135735 [Abstract] [Full Text] [Related]
32. Educational interventions and the prevention of herpes simplex virus transmission. Patel R. Herpes; 2004 Aug 01; 11 Suppl 3():155A-160A. PubMed ID: 15319085 [Abstract] [Full Text] [Related]
38. No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmission. Chen KT, Tuomala RE, Chu C, Huang ML, Watts DH, Zorrilla CD, Paul M, Hershow R, Larussa P. Am J Obstet Gynecol; 2008 Apr 01; 198(4):399.e1-5. PubMed ID: 18177832 [Abstract] [Full Text] [Related]
39. [Microbicides for preventing sexually transmitted infections: Current status and strategies for preclinical evaluation of new candidates]. Fernández Romero JA, Gil PI, Ré V, Robbiani M, Paglini G. Rev Argent Microbiol; 2014 Apr 01; 46(3):256-68. PubMed ID: 25444135 [Abstract] [Full Text] [Related]
40. CDC studies link between herpes and HIV prevention. Centers for Disease Control and Prevention. AIDS Alert; 1998 Jul 01; 13(7):81-2. PubMed ID: 11365590 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]